Last updated on June 2019
Non-Interventional Study on the Tolerability and Efficacy of IVIG
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG
-
Age: - 100 Years
-
Gender: Male or Female
Inclusion Criteria:
- Any patient who needs to be treated with a product of this class because of his/her medical condition and whom the treating physician decides to prescribe Octagam or panzyga regularly, may be included.
Exclusion Criteria:
- None
